BDBM156214 US10118915, Compound 202::US9682966, 202

SMILES Cc1noc(n1)-c1nc2ccccc2nc1N1CCC(NC2CCCC2)C(CO)C1

InChI Key InChIKey=RZWRPAFKRNQRGU-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 156214   

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM156214(US9682966, 202 | US10118915, Compound 202)
Affinity DataIC50: 187nMAssay Description:Well-known assay for kappa opioid receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent

TargetKappa-type opioid receptor(Human)
The Scripps Research Institute

US Patent
LigandPNGBDBM156214(US9682966, 202 | US10118915, Compound 202)
Affinity DataIC50: 187nMT: 2°CAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements. The carboxy terminus of the OPRK1 receptor has a 7 amino acid l...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2018
Entry Details
US Patent